by John A. Jenkins | May 8, 2025 | FDA, FOIA, FTC, News Media, SEC
The Latest Requests Logged in FOIAengine Questions about GLP-1 weight loss drugs, DOGE, cryptocurrencies, and the past conduct of Trump’s regulatory nominees are among those in newly available Freedom of Information Act requests filed by media organizations with the...
by Randy E. Miller | Apr 23, 2025 | FDA, FOIA, Hedge Funds, Pharmaceuticals
FOIAengine: Questions Seek Adverse Reports about Carvykti According to a new PoliScio Analytics analysis of early 2025 Freedom of Information Act requests, investment firm Point72 has launched a significant FOIA-driven investigation into Johnson &...
by John A. Jenkins | Apr 9, 2025 | FDA, FOIA, Medical Devices, Pharmaceuticals
FOIAengine: Revolving Door Hits Pfizer on the Way Out The revolving door between the Food and Drug Administration and the pharmaceutical industry took another fast spin when Pfizer announced that Patrizia Cavazzoni would be returning to the company as its chief...
by John A. Jenkins | Jan 8, 2025 | FDA, FOIA, Pharmaceuticals
FOIAengine: How Lilly, Novo Nordisk, Others Use FOIA Welcome to 2025. At PoliScio Analytics, we logged 45,720 federal FOIA requests into our FOIAengine database during the past 12 months. But one subject, more than most others, dominated in hundreds of requests...
by John A. Jenkins | Dec 11, 2024 | FDA, FOIA, News Media, Politics
FOIAengine: HHS Designee Is Target After Calling FDA “Corrupt” Freedom of Information Act requests from the news media about Robert F. Kennedy Jr. hit the Food and Drug Administration almost immediately after President-elect Trump announced his choice of Kennedy to...
by John A. Jenkins | Nov 6, 2024 | FDA, FOIA
FOIAengine: Media Requests Signaled Issues for a “Party Drug” Going Mainstream With 153 clinical trials to assess whether the party drug known as Ecstasy can help patients suffering from Post Traumatic Stress Disorder, optimism was high earlier this summer among...
